Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > Advantage Tetra
View:
Post by Davesnothere on Apr 27, 2021 10:06am

Advantage Tetra

Before you face off in a Head-to-Head competition, it is essential to learn as much as possible about your opponent's strengths and weaknesses. 

No doubt Dr. Guy Chamberland knows all about Morphine, what it is, how it works, etc.

On the other hand, the promoters of Morphine would know almost nothing about Tetra's QIXLEEF drug. 

Hence the advantage for Tetra, and a greater probability that Dr. Guy Chamberland already knows what the outcome will be.

I like our chances $$$$$$$

Cheers!
Comment by lscfa on Apr 27, 2021 10:50am
The clinical study is rigged to prove that QIXLEEF can be just as effective as oral tablet morphine but with less side effects because it does not have to pass through gut/liver. But in breakthrough pain are patients given morphine tablets (slow acting) or intravenous morphine or intranasal opiod spray?    
Comment by lscfa on Apr 27, 2021 10:58am
Actually the clinical trial is unfair.  An inhaled product is going to work faster than an oral tablet. Why not compare the inhaled product to intranasal spray or intravenous shot? Overall, the most appropriate therapeutic choice appears to be a rapid-onset opioid (ROO), and in particular, the nasal route of administration is the quickest and most convenient mode of administration for the ...more  
Comment by Davesnothere on Apr 27, 2021 11:00am
Add to that a recent Tweet from Dr. Guy Chamberland referencing Tetra's ARDS-003 drug in relation to the fight against COVID : Our innovative drug has the potential to fight the inflammatory response that is taking lives. What will happen to the TBP share price if either of these gets approved? Up a buck ? I think not. Cheers!
Comment by Davesnothere on Apr 27, 2021 1:40pm
As we wait for REBORN1 Trial Results, its nice to know that Tetra will be 'In Revenue', that means " MAKING MONEY " from their new drug REDUVO by the end of Q3 this year. How will the TBP share price react when that happens? Up another buck ? Probably. Cheers  REDUVO will allow Tetra to establish a revenue stream based on a synthetic cannabinoid drug for major markets ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities